Evidence map›Paper›PMID 39073774›Full record

ArticleBiometrics2024

Controlling false discovery rate for mediator selection in high-dimensional data.

Ran Dai, Ruiyang Li, Seonjoo Lee, Ying Liu

Abstract read
In one paragraph

Article in Biometrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ran DaiDepartment of Biostatistics, University of Nebraska Medical Center, Omaha, NE 68198, United States.ORCID 0000-0002-3732-2789
Ruiyang LiDepartment of Biostatistics, Columbia University, New York , NY 10032, United States.
Seonjoo LeeDepartment of Psychiatry, Columbia University, New York, NY 10032, United States.ORCID 0000-0003-3177-6357
Ying LiuDepartment of Psychiatry, Columbia University, New York, NY 10032, United States.ORCID 0000-0003-0214-6479

Funding

Tracking and Evaluation CoreU54GM115458 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GUDA, CHITTIBABU · 2016 to 2025
$42.8M
A Data Science Framework for Empirically Evaluating and Deriving Reproducible and Transferrable RDoC Constructs in YouthR01MH124106 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI SEONJOO LEE · 2020 to 2026
$3.4M
NIGMS NIH HHS U54 GM115458NIMH NIH HHS 1R01MH124106NIMH NIH HHS R01 MH124106
6 · The paper itself

Abstract

The need to select mediators from a high dimensional data source, such as neuroimaging data and genetic data, arises in much scientific research. In this work, we formulate a multiple-hypothesis testing framework for mediator selection from a high-dimensional candidate set, and propose a method, which extends the recent development in false discovery rate (FDR)-controlled variable selection with knockoff to select mediators with FDR control. We show that the proposed method and algorithm achieved finite sample FDR control. We present extensive simulation results to demonstrate the power and finite sample performance compared with the existing method. Lastly, we demonstrate the method for analyzing the Adolescent Brain Cognitive Development (ABCD) study, in which the proposed method selects several resting-state functional magnetic resonance imaging connectivity markers as mediators for the relationship between adverse childhood events and the crystallized composite score in the NIH toolbox.

Indexed as

AlgorithmsBrainComputer SimulationMagnetic Resonance ImagingAdolescentBiometryCognitionData Interpretation, StatisticalFalse Positive ReactionsHumansModels, StatisticalNeuroimagingFDRHigh-dimensional mediatorsimaging dataknockoff

Identifiers

PMID39073774
PMCPMC11285112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.